How do we identify and treat patients with BRAF-mutated mCRC?
How do we identify and treat patients with BRAF-mutated mCRC?
Asst. Prof. Joleen Hubbard, Prof. Armin Gerger
Dr. Scott Kopetz (USA) led a very interesting and interactive GI CONNECT virtual Experts Knowledge Share which addressed the question ‘How do we identify and treat patients with BRAF-mutated mCRC (metastatic colorectal cancer) today and tomorrow?' Dr. Armin Gerger and Dr. Joleen Hubbard provided the US and European perspectives on this important topic.
Asst. Prof. Joleen Hubbard
Medical Oncologist
Mayo Cinic Rochester
United States (US)
Prof. Armin Gerger
Medical Oncologist
Medical University of Vienna
Austria
| 
5 min
|
Oct 2020
download resources
I agree that this educational programme:
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.
Other programmes of interest
5 min
Other programmes developed by Asst. Prof. Joleen Hubbard
Asst. Prof. Joleen Hubbard
Medical Oncologist
Mayo Cinic Rochester
United States (US)
Other programmes developed by Prof. Armin Gerger
Prof. Armin Gerger
Medical Oncologist
Medical University of Vienna
Austria
